9 research outputs found
Oxygen saturation and reported AMS scores at different altitudes.
<p>AMS-c, cerebral score of the environmental symptoms questionnaire score; AMS-LL, acute mountain sickness according to Lake Louise AMS protocol; BC, basecamp, C1–3; camps 1–3; IQR, interquartile range; SpO<sub>2</sub>, pulse oximetric arterial oxygen saturation.</p><p>Oxygen saturation and reported AMS scores at different altitudes.</p
Oxygen saturation of all climbers during the expedition.
<p>Oxygen saturation measured by pulse oximetry of all climbers during the expedition. Oxygen saturation measurements of subjects with new findings in post-expedition MRI are indicated in color.</p
Comparison of subjects with and without new MRI findings.
<p>AMS-c, cerebral score of the environmental symptoms questionnaire score; AMS-LL, acute mountain sickness according to Lake Louise AMS protocol; SpO<sub>2</sub>, pulse oximetric arterial oxygen saturation.</p><p>Comparison of subjects with and without new MRI findings.</p
Partial volume estimate fractions at baseline and changes between baseline and post-expedition imaging.
<p>Top: Age dependence of the percentages of the partial volume estimates for cerebro-spinal fluid, grey matter and white matter during baseline testing. Means and standard deviations are reported at the bottom of the panels. Bottom: Partial volume estimates fraction change between baseline and post-expedition imagining as a function of age. Means and standard deviations are reported at the bottom of the panels. At the top of the panels the results of a one-sample t-test of the hypothesis that the mean PVE change is zero are given.</p
Imaging findings pre- and post-expedition in subjects with new microhemorrhages after the climb.
<p>Subject A: Comparison of SWI (MinIP) in pre- and post-expedition MRI shows a new solitary microhemorrhage (indicated by arrow). SWI of Subject B and SWI (MinIP) of subject C show multiple new microhemorrhages of the corpus callosum visible in post-expedition MRI (arrows).</p
Clauss fibrinogen increase after weaning from CPB, according to surgery type.
<p>Clauss fibrinogen measurements over time, starting at the time point <i>Protomine</i>. The comprehensive plots show all patients, with the three types of surgery represented by different symbols. Predictions based on the fixed effects of the three respective linear mixed-effects models are superimposed.</p
Patient demographics, procedural data and outcomes.
<p>Patient demographics, procedural data and outcomes.</p
Patient- and CPB-related factors influencing clauss fibrinogen levels and FIBTEM-MCF at <i>Protamine</i>.
<p>Patient- and CPB-related factors influencing clauss fibrinogen levels and FIBTEM-MCF at <i>Protamine</i>.</p
Patient flow diagram.
<p>CABG = coronary artery bypass grafting; AVR = aortic valve replacement; AAR = ascending aorta replacement; HCA = hypothermic circulatory arrest. n indicates number of patients.</p